Rezultati - Jan‐Henning Klusmann
- Showing 1 - 20 results of 37
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study od Jan‐Henning Klusmann, Dirk Reinhardt, Martin Zimmermann, Bernhard Kremens, Josef Vormoor, Michael Dworzak, Ursula Creutzig, T. Klingebiel
Izdano 2011Artigo -
8
CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells <i>in vivo</i> od Jana Reimer, Sabine Knöß, Maurice Labuhn, Emmanuelle Charpentier, Gudrun Göhring, Brigitte Schlegelberger, Jan‐Henning Klusmann, Dirk Heckl
Izdano 2017Artigo -
9
-
10
-
11
-
12
-
13
-
14
-
15
Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012 od Mareike Rasche, Martin Zimmermann, Lisa Borschel, Jean‐Pierre Bourquin, Michael Dworzak, Thomas Klingebiel, Thomas Lehrnbecher, Ursula Creutzig, Jan‐Henning Klusmann, Dirk Reinhardt
Izdano 2018Artigo -
16
<i>miR-99a/100∼125b</i> tricistrons regulate hematopoietic stem and progenitor cell homeostasis by shifting the balance between TGFβ and Wnt signaling od Stephan Emmrich, Mareike Rasche, Jennifer Schöning, Christina Reimer, Sarva Keihani, Aliaksandra Maroz, Ying Xie, Zhe Li, Axel Schambach, Dirk Reinhardt, Jan‐Henning Klusmann
Izdano 2014Artigo -
17
Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications od Maurice Labuhn, Felix F. Adams, Michelle Ng, Sabine Knoess, Axel Schambach, Emmanuelle Charpentier, Adrian Schwarzer, Juan L. Mateo, Jan‐Henning Klusmann, Dirk Heckl
Izdano 2017Artigo -
18
Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial od Madita Uffmann, Mareike Rasche, Martin Zimmermann, Christine von Neuhoff, Ursula Creutzig, Michael Dworzak, Lenie Scheffers, Henrik Hasle, C. Michel Zwaan, Dirk Reinhardt, Jan‐Henning Klusmann
Izdano 2017Artigo -
19
Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia od Kate Alford, Katarina Reinhardt, Catherine Garnett, Alice Norton, Katarina Böhmer, Christine von Neuhoff, Alexandra Kolenová, Emanuele Marchi, Jan‐Henning Klusmann, Irene Roberts, Henrik Hasle, Dirk Reinhardt, Paresh Vyas
Izdano 2011Artigo -
20
Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study od Marius Flasinski, Kira Scheibke, Martin Zimmermann, Ursula Creutzig, Katarina Reinhardt, Femke Verwer, Valérie de Haas, Vincent H. J. van der Velden, Christine von Neuhoff, C. Michel Zwaan, Dirk Reinhardt, Jan‐Henning Klusmann
Izdano 2018Artigo
Iskalna orodja:
Sorodne teme
Biology
Genetics
Medicine
Myeloid leukemia
Gene
Leukemia
Cancer research
Immunology
Stem cell
Myeloid
Haematopoiesis
Internal medicine
Cell biology
Oncology
microRNA
Down syndrome
Biochemistry
Progenitor cell
Hematopoietic stem cell transplantation
Psychiatry
Acute megakaryoblastic leukemia
Cancer
Environmental health
GATA1
Population
Transcription factor
Transplantation
Apoptosis
Cell
Cell culture